Neck Carcinoma — Trials

Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,419 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 464
Recruiting: 240
Ph III recruiting: 63
Growth YoY: +3.1%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (128)

clinicaltrialsPublishedShowing 451–500 of 577 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02289144	Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer	withdrawn	Phase 2	0	University of Texas Southwestern Medical CenterOTHER	1	Jul 30, 2019	clinicaltrials
NCT01309633	Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)	completed	Phase 2	80	National University Hospital, SingaporeOTHER	1	Jul 22, 2019